APA (7th ed.) Citation

X, Z., X, H., Z, Z., S, L., X, L., T, Z., . . . K, H. Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN–Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway. Dove Medical Press.

Chicago Style (17th ed.) Citation

X, Zhou, Hu X, Zhang Z, Lin S, Lin X, Zhou T, Bai Y, and Hu K. Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN–Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway. Dove Medical Press.

MLA (9th ed.) Citation

X, Zhou, et al. Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN–Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway. Dove Medical Press.